Document is current
Any future updates will be listed below
-
Authors
Clark, Rebecca A. https://orcid.org/0000-0001-8923-0301
Weerasuriya, Chathika K.
Portnoy, Allison
Mukandavire, Christinah
Quaife, Matthew
Bakker, Roel
Scarponi, Danny
Harris, Rebecca C.
Rade, Kirankumar
Mattoo, Sanjay Kumar
Tumu, Dheeraj
Menzies, Nicolas A.
White, Richard G. https://orcid.org/0000-0003-4410-6635
-
Funding
Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-001754)
- License Information
-
More Information
Article History
Received: 24 February 2023
Accepted: 20 July 2023
First Online: 4 August 2023
Declarations
:
: Not applicable.
: Not applicable.
: RCH reports employment by Sanofi Pasteur, unrelated to tuberculosis and outside the submitted work. NAM received consulting fees from The Global Fund to Fight AIDS, Tuberculosis and Malaria, and the WHO, and reports funding to their institution from the US Centers for Disease Control and Prevention, the Bill & Melinda Gates Foundation, NIH, and US Council of State and Territorial Epidemiologists. RGW is also funded for other work by the Wellcome Trust (218261/Z/19/Z), NIH (1R01AI147321-01), EDCTP (RIA208D-2505B), UK MRC (CCF 17–7779 via SET Bloomsbury), ESRC (ES/P008011/1), BMGF (OPP1084276, OPP1135288 & INV-001754), and the WHO. All other authors declare no conflicts of interest.
